Development of hyperkalemia following treatment with dapagliflozin (DAPA) in a patient with type 2 diabetes after bilateral adrenalectomy.
about
Development of hyperkalemia following treatment with dapagliflozin (DAPA) in a patient with type 2 diabetes after bilateral adrenalectomy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Development of hyperkalemia fo ...... after bilateral adrenalectomy.
@en
Development of hyperkalemia following treatment with dapagliflozin
@nl
type
label
Development of hyperkalemia fo ...... after bilateral adrenalectomy.
@en
Development of hyperkalemia following treatment with dapagliflozin
@nl
prefLabel
Development of hyperkalemia fo ...... after bilateral adrenalectomy.
@en
Development of hyperkalemia following treatment with dapagliflozin
@nl
P2093
P2860
P1433
P1476
Development of hyperkalemia fo ...... after bilateral adrenalectomy.
@en
P2093
Akihiro Tsuda
Akiyo Yamasaki
Daichi Miyaoka
Masaaki Inaba
Masafumi Kurajoh
Masanori Emoto
Norikazu Toi
Noriyuki Hayashi
Shinsuke Yamada
Shinya Nakatani
P2860
P2888
P356
10.1007/S13730-017-0286-X
P577
2017-11-13T00:00:00Z